Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|15|2612-2617

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.15, 2015-08, pp. : 2612-2617

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 326-332

Karger

Access to resources Recommend Favorite

Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 7, 2015-07 ,pp. : 1032-1037

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adenoid Cystic Carcinoma of the Skin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 20, Iss. 3, 1993-03 ,pp. : 164-170

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of a Combination of S-1 and Paclitaxel in Patients with Unresectable or Metastatic Gastric Cancer

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 37-41

Karger

Access to resources Recommend Favorite

Efficacy and safety of dovitinib in pretreated patients with advanced squamous non‐small cell lung cancer with FGFR1 amplification: A single‐arm, phase 2 study

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 3024-3031

John Wiley & Sons Inc

Access to resources Recommend Favorite